Please login to the form below

Not currently logged in
Email:
Password:

Merk Serono

This page shows the latest Merk Serono news and features for those working in and with pharma, biotech and healthcare.

Sales down at Merck Serono on Rebif pressure

Sales down at Merck Serono on Rebif pressure

Sales down at Merck Serono on Rebif pressure. New MS drugs impact pharma company’ s revenues. ... The top-line figures disguise a transformation in Merck Serono's underlying financial performance though.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Dr Holger Adelmann joins DIA EMEA Dr Holger Adelmann joins DIA EMEA

    He joined the industry in 1989 and has previously held leading positions at AstraZeneca, Bayer, Merk Serono and Tropon. ... Most recently, Dr Adelmann served as the global head of Merck Serono's clinical pharmacology and clinical biomarker operations in

  • Meeta Gulyani leaves Roche for Merck Serono Meeta Gulyani leaves Roche for Merck Serono

    Meeta Gulyani leaves Roche for Merck Serono. She joins as head of strategy and global franchises. ... Merck Serono has strengthened its emerging market experience in the senior team with the appointment of Meeta Gulyani from pharma rival Roche.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Rainmaker Healthcare Communications

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics